Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
Meghan C. Thompson, Rosemary Harrup, Catherine C. Coombs, Lindsey E. Roeker, Jeffrey J. Pu, Michael Y. Choi, Paul M. Barr, John N. Allan, Martin Šimkovič, Lori A. Leslie, Joanna Rhodes, Elise A. Chong, Manali Kamdar, Alan P Skarbnik, Frederick Lansigan, Brittany McCall, Khalid Saja, Martin J.S. Dyer, Harriet S. Walter, Marcus Lefebure, Maria Thadani‐Mulero, Michelle Boyer, Juliana M.L. Biondo, Kavita Sail, Beenish S. Manzoor, Richard R. Furman, Kurt S. Bantilan, André Goy, Tatyana Feldman, Dominic LaBella, Stephen J. Schuster, Jae H. Park, Lia Palomba, Andrew D. Zelenetz, Toby A. Eyre, Arnon P. Kater, John F. Seymour, Anthony R. Mato
Topics & Concepts
VenetoclaxChronic lymphocytic leukemiaRegimenMedicineLeukemiaOncologyInternal medicineChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentAdvanced Breast Cancer Therapies